NASDAQ

Updated Oct 30, 9:33 AM ET

NVCR

NovoCure Limited
$12.74CS band Caution

−$0.38 (2.86%) Today

Oct 30, 9:33 AM ET

About NVCR

NovoCure Ltd is an oncology company with a proprietary platform technology in the United States. Its business involves the development, manufacture, and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis, and other products and technologies for the treatment of Glioblastoma, Non-small cell lung cancer, and Pancreatic cancer. Geographically, the company derives the majority of its revenue from the United States and the rest from Germany, Japan, and other markets.

Mkt Cap
$1.5B
Volume
5.2M
52W High
$21.45
52W Low
$9.82
PE Ratio
—
Avg Vol
1.7M
As of 10/29/26
Div Yield
—
Beta
1.59
As of 10/29/26

Company

Headquarters
St. Helier
Employees
1,605 (2026)
Listed
Oct 2, 2015
Exchange
Nasdaq
Website
novocure.com
SEC industry
Surgical & Medical Instruments & Apparatus
Cylvex sector
Health Care · Medical Devices

Medical Devices

  • Market cap #48 of 163
  • P/B #46 of 152

Ranked highest first among stocks Cylvex covers.

  1. ABTAbbott Laboratories$183.0B+1.11%
  2. ISRGIntuitive Surgical Inc$157.2B-0.85%
  3. MDTMedtronic plc$124.5B+0.20%
  4. SYKStryker Corporation$111.2B-7.00%
  5. BSXBoston Scientific Corp.$61.72B-0.24%
All Medical Devices ›

Financial summary

Related companies

About

NovoCure Ltd is an oncology company with a proprietary platform technology in the United States. Its business involves the development, manufacture, and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis, and other products and technologies for the treatment of Glioblastoma, Non-small cell lung cancer, and Pancreatic cancer. Geographically, the company derives the majority of its revenue from the United States and the rest from Germany, Japan, and other markets.

From company filings and market data · Not investment advice

Price data

Day Low $12.58Day High $13.19
52W Low $9.8252W High $21.45
Open
$13.15
Prev Close
$13.11
Volume
5.2M
Avg Vol (30D)
1.7M

52W range and average volume from daily bars (unadjusted, last 252 sessions).

Financials

Consensus estimates

The information provided is for educational purposes only and does not constitute investment advice. Past performance does not guarantee future results.